Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach

Brotherton, Julia; Murray, Sharron L; Hall, Madeline; Andrewartha, Lynne K; Banks, Carolyn; Meijer, Dennis; Pitcher, Helen; Scully, Megan M; Molchanoff, Luda

doi:10.5694/mja13.10272

Cited by 109 publications

(98 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, vaccine programme and communication strategies have a very large effect on uptake. Uptake of HPV vaccines is low in the USA and Germany [9,10] and high in Australia, [11] while uptake rates in Africa vary. [12][13][14] Vaccine uptake, calculated as the proportion of girls who received one vaccine dose from the total IC, was 64.0% for the total group in this study.…”

Section: Discussionmentioning

confidence: 99%

The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa

et al. 2015

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa

et al. 2015

View full text Add to dashboard Cite

“…Other challenges included HPVV safety concerns, obtaining parental consent, variable familiarity with school-based VPs, and variation in uptake across territories. 52,58 Similarly, vaccination rates in Canada differed by province. Prince Edward Island had high rates after the sixth year of the school-based VP: 85% and 79% completion for girls and boys, respectively.…”

Section: Environmental Interventions (N = 31)mentioning

confidence: 99%

“…Barriers to implementation at all policy levels included the following: obtaining vaccination consent, 58,60,63,66 reaching adolescents not in school, 58,72,76 and reaching underserved areas. 75,77 Environmental Interventions: Small Policy (n = 12)…”

Section: Environmental Interventions (N = 31)mentioning

confidence: 99%

Interventions to Improve HPV Vaccine Uptake: A Systematic Review

Walling¹,

Benzoni²,

Dornfeld³

et al. 2016

Pediatrics

193

154

View full text Add to dashboard Cite

CONTEXT: The human papillomavirus (HPV) vaccine is a safe, effective cancer prevention method that is underutilized in the United States. Despite increased understanding of barriers to vaccination, rates remain low. Globally, developed and developing nations have achieved high rates of vaccination.OBJECTIVE: Identification of effective strategies is necessary to optimize uptake of the HPV vaccine. We systematically reviewed the literature for national and international interventions that have successfully increased HPV vaccine uptake. DATA SOURCES:We used a standardized protocol to search for articles published between January 1, 2006, and April 30, 2015, in 3 electronic databases: PubMed, Scopus, and Embase. STUDY SELECTION:We identified interventions designed to increase HPV vaccine uptake among adolescents and young adults aged 11 to 26 years. All study designs were acceptable. Only articles that included postintervention vaccination rates were included. DATA EXTRACTION:Two authors independently reviewed each article for data extraction and quality assessment. Interventions were classified according to the Community Preventive Service Task Force guide. RESULTS:Results were reported according to the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework. Fifty-one articles met eligibility criteria: 2 informational interventions, 18 behavioral interventions, and 31 environmental interventions. Factors associated with HPV vaccine uptake were increased vaccine availability, decreased financial barriers, and interventions targeting both providers and patients.LIMITATIONS: Lack of consistent RE-AIM metric reporting, limiting our ability to assess intervention validity and quality.CONCLUSIONS: Population-based vaccination strategies that increased vaccine availability reached the greatest number of adolescents and were most successful in achieving high rates of vaccination.

show abstract

“…The main vaccination analysis incorporated the HPV vaccination coverage as reported in Three scenarios were investigated. The baseline analysis used reported three-dose coverage in females (Brotherton et al 2013a, Brotherton et al 2013b, Immunise Australia 2013, and assumed equivalent age-specific coverage in males offered vaccination from 2013. A lower end scenario assumed uptake in males was only half that achieved in…”

mentioning

confidence: 99%

HPV vaccine impact in Australian women: ready for an HPV‐based screening program

Brotherton

Gertig

May

et al. 2016

Medical Journal of Australia

View full text Add to dashboard Cite

Enquiries about the content of the report should be directed to the above address.The Medical Services Advisory Committee (MSAC) is an independent committee which has been established to provide advice to the Minister for Health and Ageing on the strength of evidence available on new and existing medical technologies and procedures in terms of their safety, effectiveness and costeffectiveness. This advice will help to inform government decisions about which medical services should attract funding under Medicare. MSAC's advice does not necessarily reflect the views of all individuals who participated in the MSAC evaluation. Publication approval number: Template Version updated Nov 08Application 1276 NCSP Renewal: Modelled evaluation i Table 38 Summary of the effect of poor compliance with 5-yearly call-andrecall (high proportion of early re-screening, CR2) compared with the equivalent strategy under assumptions of better compliance with 5-yearly screening (low proportion of early re-screening, most women re-attending on time (CR1)) for primary HPV testing strategies . Table 71 Health and cost outcomes in strategies where women never return for more cervical screening after being completely discharged after a normal HPV exit test (compared to the equivalent strategy where some women continue to return after an exit test at rates as observed under current practice) and assuming screening ends at 69 instead of 64 years for both sets of scenarios -unvaccinated cohort .. Table 72 Health and cost outcomes in strategies where women never return for more cervical screening after being completely discharged after a normal HPV exit test (compared to the equivalent strategy where some women continue to return after an exit test at rates as observed under current practice) and assuming screening ends at 69 instead of 64 years for both sets of scenarios -cohort offered vaccination at age 12 . The relative trade-off between the percent increase in the mortality and the percent increase in the colposcopies compared to current practice of cervical screening using image-read LBC ( The Renewal aims to ensure the continuing success of the NCSP and that all Australian women, HPV vaccinated and unvaccinated, have access to a cervical screening program based on current evidence and best practice. The Renewal process will ensure the renewed program remains safe and continues to improve health outcomes of Australian women. Contents List of Tables List of FiguresThe objectives of the Renewal are to:1. Assess the evidence for screening tests and pathways, the screening interval, age range and commencement for both vaccinated and non-vaccinated women;2. Determine a cost-effective screening pathway and program model;3. Investigate options for improved national data collection systems and registry functions to enable policy, planning, service delivery and quality management; and 4. Assess the feasibility and acceptability of the renewed program for women.The first two objectives outlined above are being undertaken th...

show abstract

Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach

Cited by 109 publications

References 17 publications

The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa

The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South Africa

Interventions to Improve HPV Vaccine Uptake: A Systematic Review

HPV vaccine impact in Australian women: ready for an HPV‐based screening program

Contact Info

Product

Resources

About